CCL5 and breast cancer: We analyzed the coexpression of the above receptors with CCL5 in TCGA database and found that CCL5 and CCR5 had the strongest coexpression (Pearson =0.75), indicating that CCL5/CCR5 may act as a signaling pathway or complex that promotes breast cancer progression (Figure 5B).